MariMed Statistics

Total Valuation

MariMed has a market cap or net worth of 35.02 million. The enterprise value is 124.37 million.

Market Cap	35.02M
Enterprise Value	124.37M

Important Dates

The next confirmed earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

MariMed has 398.91 million shares outstanding. The number of shares has increased by 2.90% in one year.

Current Share Class	398.91M
Shares Outstanding	398.91M
Shares Change (YoY)	+2.90%
Shares Change (QoQ)	+0.68%
Owned by Insiders (%)	10.67%
Owned by Institutions (%)	2.26%
Float	332.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.22
PB Ratio	0.54
P/TBV Ratio	3.29
P/FCF Ratio	5.37
P/OCF Ratio	4.55
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.00, with an EV/FCF ratio of 19.05.

EV / Earnings	-8.59
EV / Sales	0.78
EV / EBITDA	11.00
EV / EBIT	n/a
EV / FCF	19.05

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 1.32.

Current Ratio	1.00
Quick Ratio	0.30
Debt / Equity	1.32
Debt / EBITDA	7.55
Debt / FCF	13.08
Interest Coverage	-0.31

Financial Efficiency

Return on equity (ROE) is -20.32% and return on invested capital (ROIC) is -1.61%.

Return on Equity (ROE)	-20.32%
Return on Assets (ROA)	-0.71%
Return on Invested Capital (ROIC)	-1.61%
Return on Capital Employed (ROCE)	-1.63%
Weighted Average Cost of Capital (WACC)	8.00%
Revenue Per Employee	184,557
Profits Per Employee	-16,725
Employee Count	923
Asset Turnover	0.78
Inventory Turnover	2.91

Taxes

In the past 12 months, MariMed has paid 3.59 million in taxes.

Income Tax	3.59M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.76% in the last 52 weeks. The beta is 1.15, so MariMed's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	-21.76%
50-Day Moving Average	0.08
200-Day Moving Average	0.10
Relative Strength Index (RSI)	64.88
Average Volume (20 Days)	1,012,505

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.07

Income Statement

In the last 12 months, MariMed had revenue of 159.83 million and -14.48 million in losses. Loss per share was -0.04.

Revenue	159.83M
Gross Profit	57.88M
Operating Income	-2.33M
Pretax Income	-10.86M
Net Income	-14.48M
EBITDA	9.18M
EBIT	-2.33M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 8.88 million in cash and 85.36 million in debt, giving a net cash position of -76.48 million or -0.19 per share.

Cash & Cash Equivalents	8.88M
Total Debt	85.36M
Net Cash	-76.48M
Net Cash Per Share	-0.19
Equity (Book Value)	64.73M
Book Value Per Share	0.13
Working Capital	223,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.70 million and capital expenditures -1.17 million, giving a free cash flow of 6.53 million.

Operating Cash Flow	7.70M
Capital Expenditures	-1.17M
Depreciation & Amortization	11.51M
Net Borrowing	-4.57M
Free Cash Flow	6.53M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 36.22%, with operating and profit margins of -1.46% and -9.06%.

Gross Margin	36.22%
Operating Margin	-1.46%
Pretax Margin	-6.80%
Profit Margin	-9.06%
EBITDA Margin	5.74%
EBIT Margin	-1.46%
FCF Margin	4.08%

Dividends & Yields

MariMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.90%
Shareholder Yield	-2.90%
Earnings Yield	-41.35%
FCF Yield	18.64%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MariMed has an Altman Z-Score of 0.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.05
Piotroski F-Score	2